178 related articles for article (PubMed ID: 30826268)
1. Outcomes of Evolut R Versus CoreValve After Transcatheter Aortic Valve Implantation: A Meta-Analysis.
Sun Y; Li J; Fan R; Li G; Fu M; Luo S; Ding H; Luo J
Heart Lung Circ; 2020 Feb; 29(2):288-294. PubMed ID: 30826268
[TBL] [Abstract][Full Text] [Related]
2. Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation.
Landes U; Bental T; Barsheshet A; Assali A; Vaknin Assa H; Levi A; Orvin K; Kornowski R
J Invasive Cardiol; 2017 Feb; 29(2):69-74. PubMed ID: 28145874
[TBL] [Abstract][Full Text] [Related]
3. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
[TBL] [Abstract][Full Text] [Related]
4. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison.
Giannini C; De Carlo M; Tamburino C; Ettori F; Latib AM; Bedogni F; Bruschi G; Presbitero P; Poli A; Fabbiocchi F; Violini R; Trani C; Giudice P; Barbanti M; Adamo M; Colombo P; Benincasa S; Agnifili M; Petronio AS
Int J Cardiol; 2017 Sep; 243():126-131. PubMed ID: 28595747
[TBL] [Abstract][Full Text] [Related]
5. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.
Kowalewski M; Gozdek M; Raffa GM; Słomka A; Zieliński K; Kubica J; Anisimowicz L; Kowalewski J; Landes U; Kornowski R; Lorusso R; Suwalski P
J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):226-236. PubMed ID: 30829877
[TBL] [Abstract][Full Text] [Related]
6. Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study.
Perrin N; Roffi M; Frei A; Hachulla AL; Ellenberger C; Müller H; Cikirikcioglu M; Licker M; Noble S
Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):713-719. PubMed ID: 28034684
[TBL] [Abstract][Full Text] [Related]
7. The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R.
Hellhammer K; Piayda K; Afzal S; Kleinebrecht L; Makosch M; Hennig I; Quast C; Jung C; Polzin A; Westenfeld R; Kelm M; Zeus T; Veulemans V
JACC Cardiovasc Interv; 2018 Nov; 11(22):2314-2322. PubMed ID: 30466830
[TBL] [Abstract][Full Text] [Related]
8. Improvements of Procedural Results With a New-Generation Self-Expanding Transfemoral Aortic Valve Prosthesis in Comparison to the Old-Generation Device.
Gomes B; Geis NA; Chorianopoulos E; Meder B; Leuschner F; Katus HA; Bekeredjian R
J Interv Cardiol; 2017 Feb; 30(1):72-78. PubMed ID: 27882613
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Implantation With 31-mm CoreValve Versus 34-mm Evolut R Bioprostheses from the STS/ACC TVT Registry.
Tang GHL; Reardon MJ; Kodali SK; Hermiller JB; Sorajja P; Szeto WY; Zhang A; Popma JJ
Am J Cardiol; 2019 Oct; 124(7):1091-1098. PubMed ID: 31362879
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of three different new generation transcatheter aortic valve prostheses.
Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
[TBL] [Abstract][Full Text] [Related]
12. Impact of the repositionable Evolut R CoreValve system on the need for a permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis.
Ojeda S; Hidalgo F; Romero M; Mazuelos F; Suárez de Lezo J; Martín E; Lostalo A; Luque A; González R; Fernández A; López-Aguilera J; Segura J; Guerrero N; Pan M
Catheter Cardiovasc Interv; 2020 Mar; 95(4):783-790. PubMed ID: 31062927
[TBL] [Abstract][Full Text] [Related]
13. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis.
Noble S; Stortecky S; Heg D; Tueller D; Jeger R; Toggweiler S; Ferrari E; Nietlispach F; Taramasso M; Maisano F; Grünenfelder J; Jüni P; Huber C; Carrel T; Windecker S; Wenaweser P; Roffi M
EuroIntervention; 2017 Apr; 12(18):e2170-e2176. PubMed ID: 28067197
[TBL] [Abstract][Full Text] [Related]
14. Real-world comparison of the new 34 mm self-expandable transcatheter aortic prosthesis Evolut R to its 31 mm core valve predecessor.
Kalogeras K; Kabir T; Mittal T; Mirsadraee S; Skondras E; Rahman Haley S; Zuhair M; Vavuranakis M; Tousoulis D; Dalby M; Panoulas V
Catheter Cardiovasc Interv; 2019 Mar; 93(4):685-691. PubMed ID: 30280466
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of the Self-Expandable Evolut R Valve Versus the Balloon-Expandable SAPIEN 3 Valve in Transcatheter Aortic Valve Implantation: A Meta-Analysis and Systematic Review.
Al-Abcha A; Saleh Y; Charles L; Prasad R; Baloch ZQ; Hasan MA; Abela GS
Cardiovasc Revasc Med; 2021 Apr; 25():57-62. PubMed ID: 33160895
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry.
Kalogeras K; Ruparelia N; Kabir T; Jabbour R; Naganuma T; Vavuranakis M; Nakamura S; Wang B; Sen S; Hadjiloizou N; Malik IS; Mikhail G; Dalby M; Panoulas V
Int J Cardiol; 2020 Jul; 310():120-125. PubMed ID: 32139239
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation.
Lerman TT; Levi A; Kornowski R
Int J Cardiol; 2023 Jan; 371():100-108. PubMed ID: 36130623
[TBL] [Abstract][Full Text] [Related]
18. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.
Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E
JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832
[TBL] [Abstract][Full Text] [Related]
19. Clinical consequences of consecutive self-expanding transcatheter heart valve iterations.
Kroon HG; van Gils L; Ziviello F; van Wiechen MPH; Ooms JFW; Rahhab Z; El Faquir N; Maugenest AM; Goudzwaard JA; Cummins P; Lenzen M; Kardys I; Daemen J; Mattace-Raso F; de Jaegere PPT; Van Mieghem NM
Neth Heart J; 2022 Mar; 30(3):140-148. PubMed ID: 33914259
[TBL] [Abstract][Full Text] [Related]
20. Comparison of third generation balloon-expandable Edwards Sapien 3 versus self-expandable Evolut R in transcatheter aortic valve implantation: a meta-analysis.
Li YM; Tsauo JY; Liao YB; Zhao ZG; Chen M
Ann Palliat Med; 2020 May; 9(3):700-708. PubMed ID: 32312063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
